UBV
United Bank (Virginia) Portfolio holdings
AUM $835M
1-Year Return
14.61%
This Quarter Return
+2.65%
1 Year Return
+14.61%
3 Year Return
+55.61%
5 Year Return
+104.58%
10 Year Return
+207.91%
AUM
$82.3M
AUM Growth
-$11.1M
(-12%)
Cap. Flow
-$13M
Cap. Flow
% of AUM
-15.75%
Top 10 Holdings %
Top 10 Hldgs %
42.72%
Holding
54
New
1
Increased
2
Reduced
34
Closed
8
Top Buys
| 1 |
Fortis
FTS
|
+$695K |
| 2 |
HF Sinclair
DINO
|
+$144K |
| 3 |
Abbott
ABT
|
+$55.8K |
Top Sells
| 1 |
ITC
ITC HOLDINGS CORP
ITC
|
+$1.55M |
| 2 |
T Rowe Price
TROW
|
+$1.12M |
| 3 |
WisdomTree Japan Hedged Equity Fund
DXJ
|
+$1.09M |
| 4 |
RVNC
Revance Therapeutics, Inc.
RVNC
|
+$1.06M |
| 5 |
AGN
Allergan plc
AGN
|
+$749K |
Sector Composition
| 1 | Technology | 20.4% |
| 2 | Healthcare | 15% |
| 3 | Industrials | 10.93% |
| 4 | Consumer Discretionary | 9.1% |
| 5 | Energy | 8.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Vanguard Mid-Cap ETF
VO
$87.8B
| $1.43M | 1.74% |
10,874
| – | – |
|
27
Coterra Energy
CTRA
$18.7B
| $1.24M | 1.51% |
53,205
-817
| -2% | -$19.1K |
|
28
Baxter International
BAX
$12.3B
| $1.12M | 1.36% |
25,290
-4,312
| -15% | -$191K |
|
|
29
WisdomTree Japan Hedged Equity Fund
DXJ
$3.83B
| $781K | 0.95% |
15,765
-21,921
| -58% | -$1.09M |
|
30
Archer Daniels Midland
ADM
$30B
| $745K | 0.9% |
16,320
-2,100
| -11% | -$95.9K |
|
31
Rockwell Automation
ROK
$38.5B
| $737K | 0.9% |
5,486
| – | – |
|
|
32
Fortis
FTS
$24.7B
| $695K | 0.84% |
+22,519
| New | +$695K |
|
33
Exxon Mobil
XOM
$489B
| $665K | 0.81% |
7,367
-700
| -9% | -$63.2K |
|
34
Philip Morris
PM
$254B
| $571K | 0.69% |
6,234
-1,105
| -15% | -$101K |
|
35
Coca-Cola Europacific Partners
CCEP
$40.3B
| $559K | 0.68% |
17,822
-7,352
| -29% | -$231K |
|
36
Consumer Discretionary Select Sector SPDR Fund
XLY
$24.8B
| $523K | 0.64% |
6,425
| – | – |
|
|
JCAP
37
DELISTED
Jernigan Capital, Inc.
JCAP
| $409K | 0.5% |
19,410
| – | – |
|
38
Bristol-Myers Squibb
BMY
$94.3B
| $398K | 0.48% |
6,812
| – | – |
|
39
Biogen
BIIB
$21.1B
| $366K | 0.44% |
1,291
-164
| -11% | -$46.5K |
|
|
CELG
40
DELISTED
Celgene Corp
CELG
| $330K | 0.4% |
2,848
-420
| -13% | -$48.7K |
|
41
AbbVie
ABBV
$382B
| $310K | 0.38% |
4,958
| – | – |
|
42
United Bankshares
UBSI
$5.22B
| $299K | 0.36% |
6,462
-41
| -0.6% | -$1.9K |
|
43
Amazon
AMZN
$2.5T
| $259K | 0.31% |
6,900
| – | – |
|
44
Gilead Sciences
GILD
$138B
| $230K | 0.28% |
3,216
-1,026
| -24% | -$73.4K |
|
45
Alphabet (Google) Class C
GOOG
$3.04T
| $223K | 0.27% |
5,760
-1,420
| -20% | -$55K |
|
|
46
Alphabet (Google) Class A
GOOGL
$3.04T
| $222K | 0.27% |
5,600
-680
| -11% | -$27K |
|
47
Berkshire Hathaway Class B
BRK.B
$1.06T
| – | – |
-1,730
| Closed | -$250K |
|
48
GE Aerospace
GE
$311B
| – | – |
-1,469
| Closed | -$209K |
|
49
Pfizer
PFE
$136B
| – | – |
-16,334
| Closed | -$525K |
|
50
Teva Pharmaceuticals
TEVA
$21.4B
| – | – |
-7,322
| Closed | -$337K |
|